Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses. | J Med Toxicol | 2022 | 33821435 | PubTator, text mining | PubMed |
| Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease. | Semin Cancer Biol | 2022 | 33220460 | PubTator, text mining | PubMed |
| Beyond Ipilimumab: a review of immunotherapeutic approaches in clinical trials in melanoma. | Immunother Adv | 2021 | 36284898 | PubTator, text mining | PubMed |
| Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies. | Explor Target Antitumor Ther | 2021 | 36046116 | PubTator, text mining | PubMed |
| Immunotherapy in non-small cell lung cancer: rationale, recent advances and future perspectives. | Precis Clin Med | 2021 | 35692863 | PubTator, text mining | PubMed |
| TCR-T Immunotherapy: The Challenges and Solutions. | Front Oncol | 2021 | 35145905 | PubTator, text mining | PubMed |
| Relationship between Kita-Kyushu Lung Cancer antigen-1 expression and prognosis of cases with lung squamous cell carcinoma. | Transl Cancer Res | 2021 | 35116371 | PubTator, text mining | PubMed |
| Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade. | Front Immunol | 2021 | 35069581 | PubTator, text mining | PubMed |
| Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks. | Pharmaceutics | 2021 | 35056922 | PubTator, text mining | PubMed |
| Use of tumor cell lysate to develop peptide vaccine targeting cancer-testis antigens. | Transl Lung Cancer Res | 2021 | 35004237 | PubTator, text mining | PubMed |
| The role of autoantibody detection in the diagnosis and staging of lung cancer. | Ann Transl Med | 2021 | 34988182 | PubTator, text mining | PubMed |
| Comprehensive Analysis to Identify MAGEA3 Expression Correlated With Immune Infiltrates and Lymph Node Metastasis in Gastric Cancer. | Front Oncol | 2021 | 34970496 | PubTator, text mining | PubMed |
| Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy. | Epigenomes | 2021 | 34968251 | PubTator, text mining | PubMed |
| Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective. | Pharmaceutics | 2021 | 34959397 | PubTator, text mining | PubMed |
| What Is the Role of HLA-I on Cancer Derived Extracellular Vesicles? Defining the Challenges in Characterisation and Potential Uses of This Ligandome. | Int J Mol Sci | 2021 | 34948350 | PubTator, text mining | PubMed |
| Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy. | Cancers (Basel) | 2021 | 34944843 | PubTator, text mining | PubMed |
| Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review. | Front Immunol | 2021 | 34925348 | PubTator, text mining | PubMed |
| Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox. | Immunity | 2021 | 34910940 | PubTator, text mining | PubMed |
| Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer. | Aging (Albany NY) | 2021 | 34898475 | PubTator, text mining | PubMed |
| T cell receptor (TCR) signaling in health and disease. | Signal Transduct Target Ther | 2021 | 34897277 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=34